Joel Embiid has knee surgery, next evaluation in 6 weeks
Feb 22, 2025; Philadelphia, Pennsylvania, USA; Philadelphia 76ers center Joel Embiid (21) controls the ball against Brooklyn Nets center Day'Ron Sharpe (20) during the third quarter at Wells Fargo Center. Mandatory Credit: Bill Streicher-Imagn Images Former NBA Most Valuable Player Joel Embiid underwent arthroscopic surgery on his left knee on Wednesday and will be re-evaluated in roughly six weeks, the Philadelphia 76ers said Friday.
The team's statement said the surgery was deemed successful and was performed by Dr. Jonathan L. Glashow at NYU Langone Sports Medicine Center.
Embiid was ruled out for the season back in late February as he and the Sixers weighed their options for his balky knee. They announced last week that he would have surgery for the second time in a little more than a year.
The 2022-23 NBA MVP and seven-time All-Star played in a career-low 19 games in 2024-25, first due to knee soreness and a three-game suspension for shoving a columnist in the locker room. His other injury absences this season included a sinus fracture.
When on the court, Embiid averaged 23.8 points, 8.2 rebounds and 4.5 assists per game.
It's the latest chapter of a disappointing season for the injury-plagued 76ers, who came into the season with championship hopes after signing All-Star Paul George and extending young star Tyrese Maxey. The trio of Embiid, George and Maxey played in just 15 games together, and Philadelphia (24-56) enters Friday 13th place in the 15-team Eastern Conference.
--Field Level Media
- 2026 MLB Rookie of the Year Odds: Best AL and NL Futures Bets
- Best College Basketball Bets Today: Miami Ohio Headlines Friday's Slate
- NBA Picks for March 5: Best Betting Picks on Thursday
- Arnold Palmer Invitational Betting Picks: Fleetwood, McIlroy and Lowry Bets
- Best Team USA Player Future Betting Picks for the World Baseball Classic
- Wednesday March 4th Top College Basketball Betting Picks & Predictions
- 2026 MLB MVP Picks: Best Long-Shot Bets in the AL and NL

